Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Julio R. Fernández-Massó"'
Autor:
Mauro M. Teixeira, Julio R. Fernández-Massó, Alessandra Bergami, Nadia Polentarutti, Carmen M Valenzuela-Silva, Tania Veliz-Rodriguez, Alexey Llópiz-Arzuaga, Javier Marín-Prida, Nielsen Lagumersindez-Denis, Tania Herrera-Rolo, Marcelo Nazabal-Galvez, Roberto Furlan, Luca Muzio, Eduardo Pentón-Arias, Ivette Raíces-Cruz, Giselle Pentón-Rol
Publikováno v:
Journal of Neuroimmune Pharmacology. 11:153-167
Multiple Sclerosis (MS) therapies approved so far are unable to effectively reverse the chronic phase of the disease or improve the remyelination process. Here our aim is to evaluate the effects of C-Phycocyanin (C-Pc), a biliprotein from Spirulina p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a161f404a532be68b695d803b6d4524b
https://doi.org/10.1007/s11481-015-9642-9
https://doi.org/10.1007/s11481-015-9642-9
Autor:
Nancy Pavón-Fuentes, Majel Cervantes-Llanos, Javier Marín-Prida, Julio R. Fernández-Massó, Eduardo Pentón-Arias, Beatriz Piniella-Matamoros, Hanlet Camacho-Rodríguez, Nielsen Lagumersindez-Denis, Viviana Falcón-Cama, Carmen M Valenzuela-Silva, Giselle Pentón-Rol, Ivette Raíces-Cruz, Mauro M. Teixeira
Publikováno v:
Life sciences. 194
The only three oral treatments currently available for multiple sclerosis (MS) target the relapsing forms of the disease and concerns regarding efficacy, safety and tolerability limit their use. Identifying novel oral disease-modifying therapies for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e7cb2f556ede62621a002750f9c44d1
https://pubmed.ncbi.nlm.nih.gov/29287781
https://pubmed.ncbi.nlm.nih.gov/29287781
Autor:
Maribel Guerra-Vallespi, Julio R Fernández-Massó, Osvaldo Reyes-Acosta, Hilda Garay-Pérez, Isis Torrens-Madrazo, Milaid Granadillo-Rodríguez, Brizaida Oliva-Argüelles, Isbel García, Isabel Guillén-Pérez, Daniel Palenzuela-Gardón, Dania Vázquez-Blomquist, Viviana Falcón-Cama, Osmany Mendoza-Fuentes, Orlando Borras-Hidalgo, Lidia I Novoa-Pérez, Mariela Vázquez-Castillo
Publikováno v:
Biotecnología Aplicada, Vol 31, Iss 4, Pp 328-331
In previous work, we identified the peptide comprising amino acids 32-51 on the antimicrobial protein limulus anti-LPS factor (LALF) from Limulus poliphemus, based on its capacity to bind to the bacterial lipopolysaccharide (LPS). In this study, we d
Externí odkaz:
https://doaj.org/article/c9c9eb16bc304ab88aed0f4885b54865
Autor:
Javier Marín-Prida, Carmen M Valenzuela-Silva, Seydi Pedroso Santana, Nancy Pavón-Fuentes, Gilberto L. Pardo-Andreu, Alberto Cintado-Benítez, Yssel Mendoza-Marí, Nadia Polentarutti, Federica Riva, Alexey Llópiz-Arzuaga, Livan Delgado-Roche, Eduardo Pentón-Arias, Giselle Pentón-Rol, Alieski Cruz-Ramírez, Julio R. Fernández-Massó, Marcelo Nazabal-Galvez
Publikováno v:
Toxicology and applied pharmacology. 272(1)
Since the inflammatory response and oxidative stress are involved in the stroke cascade, we evaluated here the effects of Phycocyanobilin (PCB, the C-Phycocyanin linked tetrapyrrole) on PC12 cell survival, the gene expression and the oxidative status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56bf661b66f2558b6ca66f0f2dbd7cb5
https://pubmed.ncbi.nlm.nih.gov/23732081
https://pubmed.ncbi.nlm.nih.gov/23732081
Publikováno v:
BMC Medical Genomics, Vol 11, Iss S1, Pp 1-3 (2018)
Externí odkaz:
https://doaj.org/article/e80f7209405e4221a2f7dd5401403d61